Everyone ages; it’s a fact. But as we age, must we also get sick? Scientists, engineers and clinicians are studying how cells change as we age. What they learn may help prevent the onset of disease.
Johns Hopkins Institute for NanoBioTechnology will host a half-day seminar “New Questions in Aging,” Aug. 22 from 10 a.m. until noon in the Hackerman Hall Auditorium (B-17).
Speakers include experts in the field of aging research.
Felipe Sierra, PhD is director of the National Institute of Aging Division of Aging Biology at the National Institutes of Health. He will present the talk “Geroscience: Aging as the Major Risk Factor for Chronic Disease” from 10-10:45 a.m.
Denis Wirtz, PhD, is the Theophilus H. Smoot Professor in the Chemical and Biomolecular Engineering at Johns Hopkins University and director of the Johns Hopkins Physical Sciences-Oncology Center. His talk is entitled “Single Cell Phenotyping for Studies in Aging;” 10:45 -11:00 a.m.
Jeremy Walston, MD, is the Raymond and Anna Lublin Professor of Geriatric Medicine from the Johns Hopkins University School of Medicine, Division of Geriatric Medicine and Gerontology. His talk is entitled “A Biological Platform for Chronic Disease and Late Life Decline;” 11:00 to 11:15.
Questions and discussion on this interesting topic will follow the talks. This seminar is free and open to the entire Hopkins community. Faculty, students and staff are encouraged to attend for any or all portions of this seminar. For further information about the Johns Hopkins Physical Sciences-Oncology Center, go to http://psoc.inbt.jhu.edu/about/
The Institute for NanoBioTechnology at Johns Hopkins University brings together 223 researchers from the Johns Hopkins Bloomberg School of Public Health, Krieger School of Arts and Sciences, School of Medicine, Applied Physics Laboratory, and Whiting School of Engineering to create new knowledge and new technologies at the interface of nanoscience and medicine.